Crypto Fund Trader has outlined the trading rules and objectives for its Ascend Evaluation program, setting out clear performance targets and risk parameters for participants.
Under the structure, traders are required to meet defined profit benchmarks during the evaluation stages. Phase 1 carries a profit target of 8%, while Phase 2 requires traders to achieve a 5% return. These targets must be reached in order to successfully complete each phase, qualify for withdrawals, or move toward account scaling. Once traders transition to a funded account, no fixed profit target applies.
Crypto Fund Trader Details Ascend Evaluation Rules and Risk Limits
Risk controls form a central part of the framework. The maximum daily loss is capped at 5% across all account sizes. This represents the highest amount a trader may lose in a single trading day before the account is considered in breach. In addition, the overall maximum loss is limited to 10% for all account tiers. Exceeding either the daily or total drawdown threshold results in a violation of the account rules.
The firm has also introduced restrictions around trading during high-impact economic announcements. News trading is not permitted within a two-minute window before and after the release of specified high-impact events. During this period, traders are prohibited from opening new positions or closing existing trades on the affected instrument.
Another rule prohibits the use of trade copiers. Participants in the Ascend Evaluation are not allowed to employ third-party trade copying services while managing their accounts. The restriction applies throughout the evaluation process and is intended to ensure that trading activity reflects the individual performance of each participant.
With clearly defined profit objectives and drawdown limits, the Ascend Evaluation program outlines the performance standards traders must follow when seeking funding through Crypto Fund Trader’s prop trading structure.
Also, use our Discount Code (FOREXPROPREVIEWS) for an 8% Discount or read the Review.
